We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 260

Application for an order of prohibition dismissed for formulation patent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 18 2015

The Court found that Mylan’s allegations of non-infringement and obviousness were justified. As a result, the application for prohibition was

Decision of Re-Examination Board affirmed on standard of reasonableness

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 11 2015

The Re-examination Board found the Claims of a patent obvious in light of prior art submitted by the person requesting re-examination. In so holding

Decision to remove inventor from patent upheld on judicial review

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 12 2012

In this case, Mr. Bakash contended that he was wrongly removed as a named inventor on a patent

Court of Appeal upholds decision relating to sildenafil use patent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

Pfizer Ireland Pharmaceuticals v. Apotex Inc., 2014 FCA 13 Drug: VIAGRA sildenafil In Apotex' action for impeachment of the Pfizer patent

Definition of “innovative drug” does not include variations

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s

Pfizer Canada v. Genpharm ULC and Mylan Pharmaceuticals et al

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

This is a motion brought in the context of a proceeding under the Patented Medicines (Notice of Compliance) Regulations (Regulations) pursuant to Section 6(5)(b) of the Regulations

Pleadings amendments refused on the eve of trial

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 7 2011

BMS brought a motion to strike out certain amendments made to its pleadings by Apotex

Motions judge dismisses appeal from prothonotary on motion to compel

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 28 2011

In the underlying case, Apotex has sued to impeach sanofi’s patent and sanofi and BMS have sued Apotex for infringement

Order of prohibition granted with respect to prodrug of known compound

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 25 2011

The two issues raised in this prohibition proceeding related to whether the claimed compound’s utility was demonstrated or soundly predicted, and whether the claimed compound was obvious

Statement of Claim struck for deficient pleading of infringement

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • November 10 2011

The Defendant appealed an Order of a Prothonotary, allowing an amendment of a Statement of Claim